Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosan L Lechner

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Bioethical Inquiry|March 20, 2026
Why We Need a Dynamic Right to Withdraw in Individualized Antisense Oligonucleotide Therapy DevelopmentMariia V Maksimova, Rosan L Lechner, Johannes J M van Delden, et al.
BMC Medical Ethics|May 5, 2026
Implicit ethical choices in ultra-rare therapy development: researchers' perspectives on patient selection and communication, therapy value, and accessibilityMariia V Maksimova, Rosan L Lechner, Felicia V Y L Lee-Kong, et al.
Prenatal Diagnosis|August 15, 2019
The validity of the viscero-abdominal disproportion ratio for type of surgical closure in all fetuses with an omphaloceleNina C J Peters, Annelieke Hijkoop, Rosan L Lechner, et al.
Clinical and Translational Gastroenterology|January 14, 2025
Tenascin-X Deficiency Causing Classical-Like Ehlers-Danlos Syndrome Type 1 in Humans is a Significant Risk Factor of Gastrointestinal and Tracheal RupturesJonneke E van Gurp, Rosan L Lechner, Dimitra Micha, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|March 23, 2018
Omphalocele: from diagnosis to growth and development at 2 years of ageAnnelieke Hijkoop, Nina C J Peters, Rosan L Lechner, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Bioethical Inquiry|March 20, 2026
Why We Need a Dynamic Right to Withdraw in Individualized Antisense Oligonucleotide Therapy DevelopmentMariia V Maksimova, Rosan L Lechner, Johannes J M van Delden, et al.
BMC Medical Ethics|May 5, 2026
Implicit ethical choices in ultra-rare therapy development: researchers' perspectives on patient selection and communication, therapy value, and accessibilityMariia V Maksimova, Rosan L Lechner, Felicia V Y L Lee-Kong, et al.
Prenatal Diagnosis|August 15, 2019
The validity of the viscero-abdominal disproportion ratio for type of surgical closure in all fetuses with an omphaloceleNina C J Peters, Annelieke Hijkoop, Rosan L Lechner, et al.
Clinical and Translational Gastroenterology|January 14, 2025
Tenascin-X Deficiency Causing Classical-Like Ehlers-Danlos Syndrome Type 1 in Humans is a Significant Risk Factor of Gastrointestinal and Tracheal RupturesJonneke E van Gurp, Rosan L Lechner, Dimitra Micha, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|March 23, 2018
Omphalocele: from diagnosis to growth and development at 2 years of ageAnnelieke Hijkoop, Nina C J Peters, Rosan L Lechner, et al.
Pageof 1